Doctors with special licenses no longer need to use special prescription pads that are difficult to obtain for their patients ...

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald ...

Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...

The Fair Work Commission (FWC) recently dealt with an unfair dismissal claim involving a security worker who was dismissed ...

GoodRx Holdings leverages its patented screening technology to find prescription coupons for uninsured or underinsured ...

An analysis of pharmacokinetic data showed ET-600 was bioequivalent to an FDA-approved oral desmopressin product.

The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.

ABOUT two weeks ago, the Trinidad and Tobago Pharmacy Board rejected the Chamber of Industry and Commerce’s request for a 90-day “grace period” to explore other options following a cease-and-desist ...

A large U.S. medical records study has found that adults prescribed gabapentin six or more times for chronic low back pain ...

Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...

Washington’s Substance Use Recovery Services Advisory Committee, or SURSAC, is distancing itself from recent recommendations made by a subset work group that included having the state ...

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...